Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVMD | ALNY | RPRX | ||
| Company | Revolution Medicines Inc | Alnylam Pharmaceuticals | Royalty Pharma Plc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 158.28 | 288.13 | 54.28 | ||
| High | 158.70 | 288.48 | 54.61 | ||
| Low | 153.94 | 276.94 | 53.44 | ||
| Latest | 156.58 | 281.90 | 54.21 | ||
| Change | -3.48 | -5.90 | -0.06 | ||
| % Change | -2.17% | -2.05% | -0.11% | ||
| Volume | 2,523,600 | 1,213,200 | 2,841,800 | ||
| 20-Day Average Volume | 2,861,430 | 1,071,705 | 4,161,315 | ||
| Previous Close | 160.06 | 287.80 | 54.27 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 153.04 | 294.65 | 54.51 | ||
| 20-Day Raw Stochastic | 60.42% | 14.77% | 51.17% | ||
| 20-Day Relative Strength | 57.39 | 41.92 | 56.15 | ||
| Weighted Alpha | +138.10 | -21.90 | +60.16 | ||
| Today's Opinion | 100% Buy | 100% Sell | 88% Buy | ||
| Previous Opinion | 100% Buy | 100% Sell | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.70% since 06/09/26 | -5.30% since 06/09/26 | -2.55% since 06/09/26 | ||
| Low | 141.44 on 06/10/26 | 276.94 on 06/16/26 | 53.44 on 06/16/26 | ||
| High | 160.41 on 06/15/26 | 299.70 on 06/10/26 | 56.23 on 06/10/26 | ||
| 1-Month | |||||
| %Chg | +7.50% since 05/15/26 | -1.77% since 05/15/26 | +2.57% since 05/15/26 | ||
| Low | 141.00 on 05/18/26 | 276.94 on 06/16/26 | 51.81 on 05/19/26 | ||
| High | 166.50 on 06/01/26 | 310.53 on 06/04/26 | 56.50 on 06/08/26 | ||
| 3-Month | |||||
| %Chg | +58.16% since 03/16/26 | -11.61% since 03/16/26 | +17.59% since 03/16/26 | ||
| Low | 91.52 on 03/30/26 | 276.94 on 06/16/26 | 44.73 on 03/20/26 | ||
| High | 166.50 on 06/01/26 | 343.36 on 04/14/26 | 56.50 on 06/08/26 | ||
| 6-Month | |||||
| %Chg | +101.88% since 12/16/25 | -27.93% since 12/16/25 | +41.25% since 12/16/25 | ||
| Low | 74.20 on 12/18/25 | 276.94 on 06/16/26 | 38.20 on 12/19/25 | ||
| High | 166.50 on 06/01/26 | 427.05 on 01/07/26 | 56.50 on 06/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 34,028,116 | 38,425,040 | 31,250,402 | ||
| Shares Outstanding, K | 212,596 | 133,513 | 575,832 | ||
| Annual Sales | 0 | 3,713,940,000 | 2,378,190,000 | ||
| Annual Net Income | -1,131,300,000 | 313,750,000 | 770,950,000 | ||
| Last Quarter Sales | 0 | 1,167,180,000 | 630,580,000 | ||
| Last Quarter Net Income | -453,820,000 | 205,990,000 | 294,690,000 | ||
| 60-Month Beta | 1.40 | 0.29 | 0.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.29 on 05/06/26 | 1.99 on 04/30/26 | 1.30 on 05/06/26 | ||
| Earnings Date | 08/05/26 | 07/30/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | 0.235 on 05/15/26 | ||
| Next Ex-Dividends Date | N/A | N/A | 05/15/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 77.49 | 10.82 | ||